TMCnet News

Research and Markets: Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update
[November 09, 2012]

Research and Markets: Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update


Nov 09, 2012 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/pktcvg/global) has announced the addition of the "Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update" report to their offering.



Fore Pharma's latest report 'Global Streptococcal Infections Drug Pipeline Capsule - 2012 Update' provides information on key Research and Development activities (R&D) in the global Streptococcal Infections market. It covers active Streptococcal Infections pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.


The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered: 1. Streptococcal Infections - Disease Overview 2. Streptococcal Infections Pipeline Overview 3. Streptococcal Infections Phase 3 Clinical Trial Pipeline Insights 4. Streptococcal Infections Phase 2 Clinical Trial Pipeline Insights 5. Streptococcal Infections Phase 1 Clinical Trial Pipeline Insights 6. Streptococcal Infections Preclinical Research Pipeline Insights 7. Streptococcal Infections Discovery Stage Pipeline Insights 8. Streptococcal Infections Drug Development Activities - Geographic Landscape 8.1. Streptococcal Infections R&D Activities in North America 8.2. Streptococcal Infections R&D Activities in Europe 9. Streptococcal Infections Pipeline - Licensing Activities Table 1. Streptococcal Infections Pipeline Molecules - Phase 3 Clinical Trial Table 2. Streptococcal Infections Pipeline Molecules - Phase 2 Clinical Trial Table 3. Streptococcal Infections Pipeline Molecules - Phase 1 Clinical Trial Table 4. Streptococcal Infections Pipeline Molecules - Preclinical Research Table 5. Streptococcal Infections Pipeline Molecules - Drug Discovery Table 6. Streptococcal Infections R&D Activities by Geography Table 7. Streptococcal Infections Pipeline Molecules - North America Table 8. Streptococcal Infections Pipeline Molecules - Europe Table 9. Streptococcal Infections Pipeline - Licensing Activities Figure 1. Streptococcal Infections Pipeline Molecules by R&D Stage Figure 2. Streptococcal Infections R&D Activities by Geography For more information visit http://www.researchandmarkets.com/research/pktcvg/global CONTACT: Research and Markets, Laura Wood, Senior Manager.

[email protected] Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Pharmaceuticals (http://www.researchandmarkets.com/categories.asp cat_id=16&campaign_id=pktcvg) ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected].

[ Back To TMCnet.com's Homepage ]